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The FNIP1 gene consists of a 6655 nt mRNA (using 
NM 133372 derived from AC005593.1, DQ145719.1, 
AC008695.9 and AL832008.1, the coding sequence 
extends from nt143 to nt3643) and contains 18 coding 
exons. The initiation codon is located within exon 1. 
Transcription 
Northern blot analysis revealed an about 7 kb FNIP1 
mRNA transcript that was expressed in most major 
adult tissues, with strongest expression in heart, liver
and placenta, and expression in kidney and lung, tissues 
involved in the Birt-Hogg-Dube' syndrome phenotype 
(see below). Several alternate transcripts lacking o e or 
more exons have been reported. Transcript 1 is the full-




The FNIP1 protein contains 1166 amino acids and has 
an estimated molecular weight of 130 kDa. 
Localisation 
Epitope-tagged FNIP1 expressed in HeLa cells 
localized exclusively in the cytoplasm. 
Function 
Coimmunoprecipitation studies to elucidate the 
function of folliculin (FLCN) (encoded by the tumor 
suppressor gene, BHD/FLCN, which is mutated in the 
Birt-Hogg-Dube' syndrome) identified a novel 
folliculin-interacting protein, FNIP1, which interacts 
through the C-terminus of FLCN. FNIP1 
overexpression enhanced phosphorylation of FLCN 
and phospho-FLCN preferentially bound to FNIP1. 
FNIP1 is a novel protein with no domains to suggest 
function. By coimmunoprecipitation studies FNIP1 was 
also found to interact with the heterotrimer, 5'AMP-
activated protein kinase (AMPK), a key molecule for
energy sensing and a negative regulator of mTOR 
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bound to FNIP1, was preferentially in its 
phosphorylated (active) form and FNIP1 could act as a 
substrate for AMPK phosphorylation both in vitro and 
in vivo. Inhibition of AMPK kinase activity resulted in 
reduced FNIP1 protein expression in HEK293 cells 
suggesting that phosphorylation of FNIP1 by AMPK 
may enhance protein stability. These data suggest that 
FNIP1 and its interacting partner, FLCN, may be 
involved in energy and nutrient-sensing through the
AMPK and mTOR signaling pathways. 
FNIP1 was also shown to interact with HSP90 by 
coimmunoprecipitation in HEK293 cells. 
Homology 
A comparison of FNIP1 proteins across species 
identified 5 blocks of conserved sequence with at le st 
35% similarity. FNIP1 homologs have been identified 
in Mus musculus, Gallus gallus, Xenopus tropicalis, 











Note: FNIP1 interacts with FLCN, encoded by a novel 
tumor suppressor gene, BHD/FLCN, which is mutated 
in the germline of patients with BHD syndrome. 
Disease 
Genodermatosis characterized by the triad of benign 
tumors of the hair follicle, spontaneous pneumothorax 
and kidney tumors. 
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